Acm Research Balances Growth Ambition With Margin Strain

Acm Research ((ACMR)) has held its Q4 earnings call. Read on for the main highlights of the call.

Acm Research’s latest earnings call struck a cautious but constructive tone as management balanced strong revenue growth and a fortified balance sheet against sharp margin pressure and softer shipments. Executives leaned heavily on a robust new-product pipeline and major capacity expansions to argue that today’s profitability dip is temporary, with 2026 set up as a pivotal ramp year.

Revenue Growth Outpaces Cycle Headwinds

Acm Research delivered Q4 2025 revenue of $244 million, up roughly 9% year over year, underscoring resilient demand despite a tricky wafer fab spending environment. Full-year sales climbed to $901.3 million, about 15% higher than 2024, and the company reiterated 2026 revenue guidance of $1.08 billion to $1.175 billion, implying roughly 25% growth at the midpoint.

Balance Sheet Firepower Supports Expansion Plans

The company ended 2025 with net cash of $845.5 million, up from $259.1 million a year earlier, after successful ACM Shanghai equity offerings. Total cash, cash equivalents and time deposits surged to $1.13 billion versus $441 million in 2024, giving Acm ample resources to fund R&D, capex and global expansion without near-term balance sheet strain.

Cleaning Leads While Portfolio Diversification Accelerates

Cleaning tools remained the core franchise, generating $626 million of revenue in 2025, up about 8% and accounting for roughly 69% of total sales as management claims coverage of about 95% of cleaning applications. At the same time, electroplating and advanced packaging systems excluding ECP climbed about 45% to $76 million, signaling meaningful progress in diversifying away from a single product line.

Technical Milestones Aim for Best-in-Class Performance

Management highlighted a redesigned SPM nozzle that achieved a 50 nm particle count under 20, which they called best-in-class and said eliminates routine chamber DI cleaning, improving tool uptime for customers. The company’s supercritical CO2 dry tool also showed about 40% lower CO2 consumption than competitors in demos, a potential cost and sustainability advantage for future wins.

New Wins Showcase Growing Global Reach

Acm reported its first tool installation in Singapore, delivering several single-wafer cleaning systems to a local facility and marking another step beyond its China base. Orders from three global customers for wafer-level and panel-level advanced packaging tools, including a North American customer with deliveries expected later in 2026, along with strong repeat SPM orders, point to broadening international traction.

Manufacturing Footprint Scales for Multi-Billion Output

The Lingang production and R&D center has become the company’s primary manufacturing site, with two buildings designed to support up to $3 billion in annual output as volumes scale. Acm is also accelerating investment in its Oregon facility, expected to start operations in the second half of 2026 to support U.S. customers and onshore production, backed by a roughly $200 million 2026 capex plan.

Roadmap Progress in Track, PECVD, Furnace and Panels

On the product roadmap, Acm delivered a high-throughput 300 wafers-per-hour KrF track tool for evaluation, with mass production qualification targeted in 2026 and the first Ultra Lith BK system now in customers’ hands. The company also shipped a horizontal panel-level electroplating tool to a large panel customer and argues its horizontal approach offers a competitive edge over vertical plating architectures.

Gross Margin Hit by Mix and Provisions

Profitability took a notable step back as Q4 2025 gross margin fell to 41.0%, below the long-term 42% to 48% target range and roughly 8.8 percentage points lower year on year. For the full year, gross margin slid to 44.5% from 50.4% in 2024, with management citing unfavorable product mix and higher inventory provisions as key drivers of the compression.

Shipments Decline on Pushed-Out New Products

Total shipments fell to $854 million in 2025 from $973 million in 2024, a drop of roughly 12.2%, while Q4 shipments of $228 million were down about 13.5% year over year. Management pointed to timing issues, noting that some new-product shipments were pushed into 2026, which depressed near-term shipment metrics but may set the stage for a stronger ramp next year.

Operating and Net Income Under Pressure

The margin squeeze flowed through to earnings as Q4 operating income declined to $29.5 million from $52.8 million a year earlier, with the operating margin sliding to 12.1% from 23.6%. For 2025 overall, operating margin dropped to 15.9% from 25.6%, while net income attributable to Acm Research fell to $110.2 million and diluted EPS decreased to $1.61 from $2.26.

Rising OpEx and R&D Spend Weigh on Leverage

Operating expenses rose sharply, with Q4 OpEx climbing about 21% to $70.6 million and full-year OpEx up roughly 34% to $258.4 million as the company invested for future growth. R&D reached 15.1% of sales in 2025 and is expected to rise further to 16% to 18% in 2026, which management acknowledged will pressure near-term operating leverage even as it underpins long-term product competitiveness.

Inventory Build and Provisions Cloud Profitability

Year-end inventory swelled to $702.6 million, reflecting both growth plans and seasonal dynamics, but it also contributed to margin headwinds through higher provisions. Management said seasonal inventory provisions alone shaved about four percentage points off Q4 gross margin, and one-time inventory adjustments further weighed on reported profitability.

Competitive Intensity and Customer Concentration Risks

Executives flagged a flood of new local entrants in China, which is intensifying price competition, particularly for semi-critical products and pressuring margins. Customer concentration remains high as the top four customers accounted for roughly 52.2% of 2025 sales, leaving Acm exposed if any key relationship weakens or demand patterns shift.

Margin Recovery Path Hinges on Execution

Management expects 2026 operating margin to remain in the mid-teens, similar to 2025, with gross margins at the low end of the 42% to 48% target in the first half before improving in the second half. That outlook implies only a gradual margin rebound and depends heavily on the timing and scale of new-product ramps, making execution on the broader portfolio rollout a central investor watchpoint.

Guidance Signals Strong Growth but Measured Profitability

Looking ahead, Acm reiterated 2026 revenue guidance of $1.08 billion to $1.175 billion and said shipment growth should outpace revenue growth, with H2 accounting for roughly 57% to 58% of sales. The company expects gross margins within its 42% to 48% long-term band but at the low end in early 2026, mid-teens operating margins, elevated R&D at 16% to 18% of sales and about $200 million in capex to support Lingang, the mini-line and the Oregon ramp as it pursues a longer-term $4 billion revenue target.

Acm Research’s earnings call painted a picture of a high-growth chip equipment supplier trading near-term margin comfort for future scale and technology leadership. With a cash-rich balance sheet, ambitious capacity build-out and promising new products, the story now rests on whether management can navigate competition, concentration risks and execution on its 2026 ramp without further eroding profitability.